Freeman, MD, J. FDA Approves Alzheimer’s Drug Against the Recommendation of Its Scientific Panel. Be Very Concerned. rrnmf 2021, 2 (5), 5-6. https://doi.org/10.17161/rrnmf.v2i5.15979.